-Minyanville

Other Tools: Calculators | My Watchlist | My Portfolio

CELL THERAPEUTICS Add to My Watchlist

(NSDQ: CTIC)

Detailed Quote

Last Price	1.08 (11.20.09 5:20 PM EST)
Change (%)	-0.03 (-2.70%)
Volume	6,273,596
Open	1.07
Previous Close	1.11
Day's Range	1.09 - 1.06
Bid / Ask	1.08 / 1.09

Intraday

3 Month

6 Month

1 Year

Average Volume	20,058,800	Shares Outstanding	574.43M
52-Week Range	0.01 - 2.23	Market Cap	620.4M
P/E Ratio	0.2	Earnings Per Share	6.48
Dividend	N/A	Yield	N/A

Symbol	Last	Change (%)
CBST	16.95	-0.10 (-0.59%)
PDLI	7.90	-0.11 (-1.37%)
SGEN	9.30	-0.04 (-0.43%)
SVNT	13.81	-0.19 (-1.36%)
INCY	7.55	-0.17 (-2.20%)

Tue, Sep 29, 2009
	Tuesday's biggest gaining and declining stocks Among the companies whose shares are expected to see active trade in Tuesday’s session are Big 5, Cell Therapeutics, Google, Nova Measuring Instruments, Starbucks, Sequenom, Siemens, Silicon Storage, and Warner Music Group. - MarketWatch
Mon, Aug 24, 2009
	Warner Chilcott rallies as drug stocks ease Drug stocks ease in early action Monday, while shares of Ireland-based Warner Chilcott PLC rally after the company announced it would buy Procter & Gamble's branded pharmaceuticals unit. - MarketWatch
	Monday's biggest gaining and declining stocks MarketWatch's daily rundown of major gainers and decliners in the stock market. - MarketWatch
Wed, Jul 29, 2009
	Short Sellers Make Wrong Bets So Far (ETFC, SBUX, CTIC, AMAT) Short sellers increase bearish bets on several companies reporting earnings, but have so far been wrong. - Investopedia
Wed, Jun 24, 2009
	Drug stocks hug flat line; Cell Therapeutics gains Drug stocks hug the flat line as shares of Cell Therapeutics Inc. advanced on news that it has fully submitted its application to U.S. regulators to market its new oncology drug pixantrone. - MarketWatch
More Featured Content

Fri, Nov 20, 2009
	Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group - PR Newswire
Mon, Nov 16, 2009
	RidgewaterEquity.com Free Fundamental Sector & Market Research on NITE, TIBX, CTIC, KLAC, BMRN and ETFC NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Ridgewater Equity (RWE). - Marketwire
Thu, Nov 05, 2009
	AnalystChoice.com Initiates Research on CTIC, KLAC, UAUA, BRCD, TTWO and FNFG NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by AnalystChoice.com (AC). - Marketwire
	Cell Therapeutics Decreases Net Loss for Nine Month Period in 2009 Compared to Same Period in 2008 by 45% - PR Newswire
Mon, Nov 02, 2009
	Trading Review for Cell Therapeutics Incorporated Issued by Beacon Equity - GlobeNewswire
More Press Releases

11/05/09		Q3 2009 Earnings Archive for CTIC
10/29/09		Special Conference Cell Therapeutics, Inc. at The 8th Annual BIO Investor Forum Archive for CTIC
10/20/09		Shareholder Meeting Annual Meeting of Shareholders Archive for CTIC
09/09/09		Special Conference Rodman and Renshaw Healthcare Conference Archive for CTIC
03/24/09		Shareholder Meeting CTI Special Meeting of Shareholders Archive for CTIC

Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Todd Harrison

Terry Woo

Kevin Depew

Jeff Macke

Andrew Jeffery

Jeffrey Cooper

Dr Janice Dorn

Allan Dodds Frank

John Mauldin

Smita Sadana